These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26303134)

  • 21. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.
    Min SB; Nylund CM; Baker TP; Ally M; Reinhardt B; Chen YJ; Nazareno L; Moawad FJ
    J Clin Gastroenterol; 2017 Feb; 51(2):127-135. PubMed ID: 27479142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms.
    Schoepfer AM; Simko A; Bussmann C; Safroneeva E; Zwahlen M; Greuter T; Biedermann L; Vavricka S; Godat S; Reinhard A; Saner C; Maye H; Sempoux C; Brunel C; Blanchard C; Simon D; Simon HU; Straumann A
    Am J Gastroenterol; 2018 Mar; 113(3):348-357. PubMed ID: 29336433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation.
    Simon D; Radonjic-Hösli S; Straumann A; Yousefi S; Simon HU
    Allergy; 2015 Apr; 70(4):443-52. PubMed ID: 25620273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.
    Assa'ad AH; Gupta SK; Collins MH; Thomson M; Heath AT; Smith DA; Perschy TL; Jurgensen CH; Ortega HG; Aceves SS
    Gastroenterology; 2011 Nov; 141(5):1593-604. PubMed ID: 21835135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Filaggrin and tight junction proteins are crucial for IL-13-mediated esophageal barrier dysfunction.
    Wu L; Oshima T; Li M; Tomita T; Fukui H; Watari J; Miwa H
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G341-G350. PubMed ID: 29746170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
    Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
    Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis.
    Chen JW; Pandolfino JE; Lin Z; Ciolino JD; Gonsalves N; Kahrilas PJ; Hirano I
    Endoscopy; 2016 Sep; 48(9):794-801. PubMed ID: 27200524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
    Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
    Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin αM activation and upregulation on esophageal eosinophils and periostin-mediated eosinophil survival in eosinophilic esophagitis.
    Vimalathas P; Farris A; Letner D; Deshpande V; Yajnik V; Shreffler W; Garber J
    Immunol Cell Biol; 2018 Apr; 96(4):426-438. PubMed ID: 29424023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of esophageal eosinophilic infiltration in patients with achalasia and response to Heller myotomy and Dor fundoplication.
    Cools-Lartigue J; Chang SY; Mckendy K; Mayrand S; Marcus V; Fried GM; Ferri LE
    Dis Esophagus; 2013; 26(8):766-75. PubMed ID: 22891632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.
    Clayton F; Fang JC; Gleich GJ; Lucendo AJ; Olalla JM; Vinson LA; Lowichik A; Chen X; Emerson L; Cox K; O'Gorman MA; Peterson KA
    Gastroenterology; 2014 Sep; 147(3):602-9. PubMed ID: 24907494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
    Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
    Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis.
    Simon D; Page B; Vogel M; Bussmann C; Blanchard C; Straumann A; Simon HU
    Allergy; 2018 Jan; 73(1):239-247. PubMed ID: 28712126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eosinophilic esophagitis in an octogenarian: A case report and review of the literature.
    Trifan A; Stoica O; Chihaia CA; Danciu M; Stanciu C; Singeap AM
    Medicine (Baltimore); 2016 Oct; 95(41):e5169. PubMed ID: 27741150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-Hour Esophageal String Test: A Nonendoscopic Minimally Invasive Test That Accurately Detects Disease Activity in Eosinophilic Esophagitis.
    Ackerman SJ; Kagalwalla AF; Hirano I; Gonsalves N; Katcher PM; Gupta S; Wechsler JB; Grozdanovic M; Pan Z; Masterson JC; Du J; Fantus RJ; Alumkal P; Lee JJ; Ochkur S; Ahmed F; Capocelli K; Melin-Aldana H; Biette K; Dubner A; Amsden K; Keeley K; Sulkowski M; Zalewski A; Atkins D; Furuta GT
    Am J Gastroenterol; 2019 Oct; 114(10):1614-1625. PubMed ID: 31567192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis.
    Butz BK; Wen T; Gleich GJ; Furuta GT; Spergel J; King E; Kramer RE; Collins MH; Stucke E; Mangeot C; Jackson WD; O'Gorman M; Abonia JP; Pentiuk S; Putnam PE; Rothenberg ME
    Gastroenterology; 2014 Aug; 147(2):324-33.e5. PubMed ID: 24768678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Japanese case series of 12 patients with esophageal eosinophilia.
    Abe Y; Iijima K; Ohara S; Koike T; Ara N; Uno K; Asano N; Imatani A; Kato K; Shibuya D; Shimosegawa T
    J Gastroenterol; 2011 Jan; 46(1):25-30. PubMed ID: 20686904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophilic oesophagitis in children: responders and non-responders to swallowed fluticasone.
    Boldorini R; Mercalli F; Oderda G
    J Clin Pathol; 2013 May; 66(5):399-402. PubMed ID: 23393202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia.
    Vanheel H; Vicario M; Vanuytsel T; Van Oudenhove L; Martinez C; Keita ÅV; Pardon N; Santos J; Söderholm JD; Tack J; Farré R
    Gut; 2014 Feb; 63(2):262-71. PubMed ID: 23474421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts.
    Peterson KA; Gleich GJ; Limaye NS; Crispin H; Robson J; Fang J; Saffari H; Clayton F; Leiferman KM
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 31310661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.